TS
Tripti Sapra
About Tripti Sapra
Data last updated:
Tripti Sapra is an Additional Director at Baxter Pharmaceuticals India Private Limited (since 2024), Director at Baxter Pharmaceuticals India Private Limited (since 2024) and Additional Director at Baxter India Private Limited (since 2024). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1,848 Cr; the largest is Baxter Pharmaceuticals India Private Limited at ₹672 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 01 Oct 2024 | 2005 | ₹672 Cr (FY 2025) | Active | |
| Director | 01 Oct 2024 | 2005 | ₹672 Cr (FY 2025) | Active | |
| Additional Director | 15 Oct 2024 | 1996 | ₹505 Cr (FY 2024) | Active |
Board colleagues of Tripti Sapra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anurag Bharatkumar Pachchigar | 10776295 | Baxter Pharmaceuticals India Private Limited , Baxter Pharmaceuticals India Private Limited | Additional Director |
| Anuranjan Naresh | 02822684 | Baxter Pharmaceuticals India Private Limited , Baxter Pharmaceuticals India Private Limited and 1 more | Additional Director |
| Ashwin Prakash Upasane | 11132124 | Baxter Pharmaceuticals India Private Limited , Baxter Pharmaceuticals India Private Limited | Additional Director |
| Gurjeet Singh Bedi | 10875091 | Baxter Pharmaceuticals India Private Limited , Baxter Pharmaceuticals India Private Limited | Additional Director |
| Sanju Dhawan | 09224741 | Baxter Pharmaceuticals India Private Limited , Baxter Pharmaceuticals India Private Limited | Director |
| Ajay Bijani | 10452933 | Baxter India Private Limited | Director |
| Deepali Kakkar | Baxter India Private Limited | Company Secretary | |
| Shalini Naagar | 03230079 | Baxter India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tripti Sapra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tripti Sapra
Tripti Sapra currently holds 3 directorships: Baxter Pharmaceuticals India Private Limited (Additional Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter Pharmaceuticals India Private Limited (Director, since 01 Oct 2024, revenue ₹672 Cr (FY 2025)); Baxter India Private Limited (Additional Director, since 15 Oct 2024, revenue ₹505 Cr (FY 2024)).
Tripti Sapra was first appointed on 01 Oct 2024 as Additional Director at Baxter Pharmaceuticals India Private Limited.
The 3 current companies of Tripti Sapra that report revenue have a combined latest revenue of ₹1,848 Cr: Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter Pharmaceuticals India Private Limited ₹672 Cr (FY 2025); Baxter India Private Limited ₹505 Cr (FY 2024).
The current boards of Tripti Sapra's companies include Anurag Bharatkumar Pachchigar (Baxter Pharmaceuticals India Private Limited), Anuranjan Naresh (Baxter Pharmaceuticals India Private Limited), Ashwin Prakash Upasane (Baxter Pharmaceuticals India Private Limited), Gurjeet Singh Bedi (Baxter Pharmaceuticals India Private Limited), Sanju Dhawan (Baxter Pharmaceuticals India Private Limited), Ajay Bijani (Baxter India Private Limited), among others.